Effect of inhibition of oxidative phosphorylation on incorporation of inorganic phosphate (P32) into liver mitochondrial ATP and phospholipids.
D000255:Adenosine Triphosphate / Q000096:biosynthesis*; D000818:Animals; D001152:Arsenicals / Q000494:pharmacology*; D004140:Dinitrophenols / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology*; D008275:Magnesium Deficiency; D008928:Mitochondria / Q000378:metabolism*; D009206:Myocardium / Q000166:cytology; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010710:Phosphates / Q000378:metabolism*; D010743:Phospholipids / Q000096:biosynthesis; D051381:Rats; D013347:Subcellular Fractions / Q000378:metabolism
D001152:Arsenicals; D004140:Dinitrophenols; D010710:Phosphates; D010743:Phospholipids; D000255:Adenosine Triphosphate